Implementation Strategies to Increase PrEP Uptake in the South
Purpose of Review Seven years after TDF/FTC was approved for pre-exposure prophylaxis to reduce risks of HIV infection, there have been large increases in the number of persons using PrEP in the USA. However, recent data on pre-exposure prophylaxis (PrEP) use at the state level indicate that people...
Gespeichert in:
Veröffentlicht in: | Current HIV/AIDS reports 2019-08, Vol.16 (4), p.259-269 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 269 |
---|---|
container_issue | 4 |
container_start_page | 259 |
container_title | Current HIV/AIDS reports |
container_volume | 16 |
creator | Sullivan, Patrick S. Mena, Leandro Elopre, Latesha Siegler, Aaron J. |
description | Purpose of Review
Seven years after TDF/FTC was approved for pre-exposure prophylaxis to reduce risks of HIV infection, there have been large increases in the number of persons using PrEP in the USA. However, recent data on pre-exposure prophylaxis (PrEP) use at the state level indicate that people living in the Southern United States are underserved by PrEP relative to their epidemic need. We sought to review possible reasons for inequitable uptake of PrEP in the South and identify implementation approaches to increase PrEP uptake in the South.
Recent Findings
Published literature, data on the locations of PrEP service providers, recent data on PrEP utilization from pharmacy prescription databases, HIV surveillance data and government data on healthcare providers, and health literacy indicate a confluence of factors in the South that are likely limiting PrEP uptake. A variety of approaches are needed to address the complex challenges to PrEP implementation in the South. These include considering alternative PrEP provision strategies (e.g., pharmacy-based PrEP, telemedicine-delivered PrEP), conducting gain-based stigma-reduction campaigns, increasing capacity for reimbursement for PrEP medications and services through policy change to expand Medicaid and to preserve access to Affordable Care Act–compliant health plans, expanding STI screening programs and improving integration of PrEP offering with delivery of positive STI results, using mHealth tools to screen groups at highest risk for HIV (e.g., men who have sex with men) periodically to increase correct perception of risk, and streamlining clinical procedures to allow same-day PrEP starts for patients without obvious medical contraindications.
Summary
Overcoming the structural, capacity, and policy challenges to increasing PrEP uptake in the South will require innovations in clinical approaches, leveraging technologies, and policy changes. The South has unique challenges to achieving equitable PrEP uptake, and addressing key barriers to expanded PrEP use will require multisectoral responses. |
doi_str_mv | 10.1007/s11904-019-00447-4 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7117066</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2255457893</sourcerecordid><originalsourceid>FETCH-LOGICAL-c474t-12dc84695b94ff2eff5ff9c9f0b99c5bb394f07d7d32ec02e91b03140180b62c3</originalsourceid><addsrcrecordid>eNp9kU9P3DAQxa0KVCj0C_SAInHpJWX8J3F8QaoQ0JWQWGnhbDne8W5oEm9tB6nfHsPSbemB01gzv3mep0fIFwrfKIA8i5QqECVQVQIIIUvxgRzSSjQlr2S9t3vXzQH5FOMDABdK1B_JAadUSl7zQ3I-GzY9Djgmkzo_FosUTMJVh7FIvpiNNqCJWMzD5by43yTzE4tuLNIai4Wf0vqY7DvTR_z8Wo_I_dXl3cWP8ub2enbx_aa0QopUUra0jahV1SrhHEPnKueUVQ5apWzVtjz3QS7lkjO0wFDRFjgVQBtoa2b5ETnf6m6mdsClzfcG0-tN6AYTfmtvOv12MnZrvfKPWmanUNdZ4OurQPC_JoxJD1202PdmRD9FzVhViUo2imf09D_0wU9hzPaeqYZBdiIzxbaUDT7GgG53DAX9HI_exqNzPPolHi3y0sm_NnYrf_LIAN8CMY_GFYa_f78j-wT-gJqY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2258208467</pqid></control><display><type>article</type><title>Implementation Strategies to Increase PrEP Uptake in the South</title><source>MEDLINE</source><source>SpringerLink Journals</source><creator>Sullivan, Patrick S. ; Mena, Leandro ; Elopre, Latesha ; Siegler, Aaron J.</creator><creatorcontrib>Sullivan, Patrick S. ; Mena, Leandro ; Elopre, Latesha ; Siegler, Aaron J.</creatorcontrib><description>Purpose of Review
Seven years after TDF/FTC was approved for pre-exposure prophylaxis to reduce risks of HIV infection, there have been large increases in the number of persons using PrEP in the USA. However, recent data on pre-exposure prophylaxis (PrEP) use at the state level indicate that people living in the Southern United States are underserved by PrEP relative to their epidemic need. We sought to review possible reasons for inequitable uptake of PrEP in the South and identify implementation approaches to increase PrEP uptake in the South.
Recent Findings
Published literature, data on the locations of PrEP service providers, recent data on PrEP utilization from pharmacy prescription databases, HIV surveillance data and government data on healthcare providers, and health literacy indicate a confluence of factors in the South that are likely limiting PrEP uptake. A variety of approaches are needed to address the complex challenges to PrEP implementation in the South. These include considering alternative PrEP provision strategies (e.g., pharmacy-based PrEP, telemedicine-delivered PrEP), conducting gain-based stigma-reduction campaigns, increasing capacity for reimbursement for PrEP medications and services through policy change to expand Medicaid and to preserve access to Affordable Care Act–compliant health plans, expanding STI screening programs and improving integration of PrEP offering with delivery of positive STI results, using mHealth tools to screen groups at highest risk for HIV (e.g., men who have sex with men) periodically to increase correct perception of risk, and streamlining clinical procedures to allow same-day PrEP starts for patients without obvious medical contraindications.
Summary
Overcoming the structural, capacity, and policy challenges to increasing PrEP uptake in the South will require innovations in clinical approaches, leveraging technologies, and policy changes. The South has unique challenges to achieving equitable PrEP uptake, and addressing key barriers to expanded PrEP use will require multisectoral responses.</description><identifier>ISSN: 1548-3568</identifier><identifier>ISSN: 1548-3576</identifier><identifier>EISSN: 1548-3576</identifier><identifier>DOI: 10.1007/s11904-019-00447-4</identifier><identifier>PMID: 31177363</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Anti-HIV Agents - therapeutic use ; Emtricitabine - therapeutic use ; Epidemics ; HIV ; HIV Infections - drug therapy ; HIV Infections - prevention & control ; Homosexuality, Male ; Human immunodeficiency virus ; Humans ; Implementation Science (E Geng ; Male ; Mass Screening ; Medication Adherence - psychology ; Medicine ; Medicine & Public Health ; Patient Protection and Affordable Care Act ; Pharmacy ; Pre-Exposure Prophylaxis - methods ; Prophylaxis ; Safe Sex - psychology ; Section Editor ; Sexual and Gender Minorities ; Social Stigma ; Telemedicine ; Tenofovir - therapeutic use ; Topical Collection on Implementation Science ; United States</subject><ispartof>Current HIV/AIDS reports, 2019-08, Vol.16 (4), p.259-269</ispartof><rights>Springer Science+Business Media, LLC, part of Springer Nature 2019</rights><rights>Copyright Springer Nature B.V. 2019</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c474t-12dc84695b94ff2eff5ff9c9f0b99c5bb394f07d7d32ec02e91b03140180b62c3</citedby><cites>FETCH-LOGICAL-c474t-12dc84695b94ff2eff5ff9c9f0b99c5bb394f07d7d32ec02e91b03140180b62c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s11904-019-00447-4$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s11904-019-00447-4$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>230,314,776,780,881,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31177363$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sullivan, Patrick S.</creatorcontrib><creatorcontrib>Mena, Leandro</creatorcontrib><creatorcontrib>Elopre, Latesha</creatorcontrib><creatorcontrib>Siegler, Aaron J.</creatorcontrib><title>Implementation Strategies to Increase PrEP Uptake in the South</title><title>Current HIV/AIDS reports</title><addtitle>Curr HIV/AIDS Rep</addtitle><addtitle>Curr HIV/AIDS Rep</addtitle><description>Purpose of Review
Seven years after TDF/FTC was approved for pre-exposure prophylaxis to reduce risks of HIV infection, there have been large increases in the number of persons using PrEP in the USA. However, recent data on pre-exposure prophylaxis (PrEP) use at the state level indicate that people living in the Southern United States are underserved by PrEP relative to their epidemic need. We sought to review possible reasons for inequitable uptake of PrEP in the South and identify implementation approaches to increase PrEP uptake in the South.
Recent Findings
Published literature, data on the locations of PrEP service providers, recent data on PrEP utilization from pharmacy prescription databases, HIV surveillance data and government data on healthcare providers, and health literacy indicate a confluence of factors in the South that are likely limiting PrEP uptake. A variety of approaches are needed to address the complex challenges to PrEP implementation in the South. These include considering alternative PrEP provision strategies (e.g., pharmacy-based PrEP, telemedicine-delivered PrEP), conducting gain-based stigma-reduction campaigns, increasing capacity for reimbursement for PrEP medications and services through policy change to expand Medicaid and to preserve access to Affordable Care Act–compliant health plans, expanding STI screening programs and improving integration of PrEP offering with delivery of positive STI results, using mHealth tools to screen groups at highest risk for HIV (e.g., men who have sex with men) periodically to increase correct perception of risk, and streamlining clinical procedures to allow same-day PrEP starts for patients without obvious medical contraindications.
Summary
Overcoming the structural, capacity, and policy challenges to increasing PrEP uptake in the South will require innovations in clinical approaches, leveraging technologies, and policy changes. The South has unique challenges to achieving equitable PrEP uptake, and addressing key barriers to expanded PrEP use will require multisectoral responses.</description><subject>Anti-HIV Agents - therapeutic use</subject><subject>Emtricitabine - therapeutic use</subject><subject>Epidemics</subject><subject>HIV</subject><subject>HIV Infections - drug therapy</subject><subject>HIV Infections - prevention & control</subject><subject>Homosexuality, Male</subject><subject>Human immunodeficiency virus</subject><subject>Humans</subject><subject>Implementation Science (E Geng</subject><subject>Male</subject><subject>Mass Screening</subject><subject>Medication Adherence - psychology</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Patient Protection and Affordable Care Act</subject><subject>Pharmacy</subject><subject>Pre-Exposure Prophylaxis - methods</subject><subject>Prophylaxis</subject><subject>Safe Sex - psychology</subject><subject>Section Editor</subject><subject>Sexual and Gender Minorities</subject><subject>Social Stigma</subject><subject>Telemedicine</subject><subject>Tenofovir - therapeutic use</subject><subject>Topical Collection on Implementation Science</subject><subject>United States</subject><issn>1548-3568</issn><issn>1548-3576</issn><issn>1548-3576</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kU9P3DAQxa0KVCj0C_SAInHpJWX8J3F8QaoQ0JWQWGnhbDne8W5oEm9tB6nfHsPSbemB01gzv3mep0fIFwrfKIA8i5QqECVQVQIIIUvxgRzSSjQlr2S9t3vXzQH5FOMDABdK1B_JAadUSl7zQ3I-GzY9Djgmkzo_FosUTMJVh7FIvpiNNqCJWMzD5by43yTzE4tuLNIai4Wf0vqY7DvTR_z8Wo_I_dXl3cWP8ub2enbx_aa0QopUUra0jahV1SrhHEPnKueUVQ5apWzVtjz3QS7lkjO0wFDRFjgVQBtoa2b5ETnf6m6mdsClzfcG0-tN6AYTfmtvOv12MnZrvfKPWmanUNdZ4OurQPC_JoxJD1202PdmRD9FzVhViUo2imf09D_0wU9hzPaeqYZBdiIzxbaUDT7GgG53DAX9HI_exqNzPPolHi3y0sm_NnYrf_LIAN8CMY_GFYa_f78j-wT-gJqY</recordid><startdate>20190801</startdate><enddate>20190801</enddate><creator>Sullivan, Patrick S.</creator><creator>Mena, Leandro</creator><creator>Elopre, Latesha</creator><creator>Siegler, Aaron J.</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20190801</creationdate><title>Implementation Strategies to Increase PrEP Uptake in the South</title><author>Sullivan, Patrick S. ; Mena, Leandro ; Elopre, Latesha ; Siegler, Aaron J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c474t-12dc84695b94ff2eff5ff9c9f0b99c5bb394f07d7d32ec02e91b03140180b62c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Anti-HIV Agents - therapeutic use</topic><topic>Emtricitabine - therapeutic use</topic><topic>Epidemics</topic><topic>HIV</topic><topic>HIV Infections - drug therapy</topic><topic>HIV Infections - prevention & control</topic><topic>Homosexuality, Male</topic><topic>Human immunodeficiency virus</topic><topic>Humans</topic><topic>Implementation Science (E Geng</topic><topic>Male</topic><topic>Mass Screening</topic><topic>Medication Adherence - psychology</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Patient Protection and Affordable Care Act</topic><topic>Pharmacy</topic><topic>Pre-Exposure Prophylaxis - methods</topic><topic>Prophylaxis</topic><topic>Safe Sex - psychology</topic><topic>Section Editor</topic><topic>Sexual and Gender Minorities</topic><topic>Social Stigma</topic><topic>Telemedicine</topic><topic>Tenofovir - therapeutic use</topic><topic>Topical Collection on Implementation Science</topic><topic>United States</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sullivan, Patrick S.</creatorcontrib><creatorcontrib>Mena, Leandro</creatorcontrib><creatorcontrib>Elopre, Latesha</creatorcontrib><creatorcontrib>Siegler, Aaron J.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Current HIV/AIDS reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sullivan, Patrick S.</au><au>Mena, Leandro</au><au>Elopre, Latesha</au><au>Siegler, Aaron J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Implementation Strategies to Increase PrEP Uptake in the South</atitle><jtitle>Current HIV/AIDS reports</jtitle><stitle>Curr HIV/AIDS Rep</stitle><addtitle>Curr HIV/AIDS Rep</addtitle><date>2019-08-01</date><risdate>2019</risdate><volume>16</volume><issue>4</issue><spage>259</spage><epage>269</epage><pages>259-269</pages><issn>1548-3568</issn><issn>1548-3576</issn><eissn>1548-3576</eissn><abstract>Purpose of Review
Seven years after TDF/FTC was approved for pre-exposure prophylaxis to reduce risks of HIV infection, there have been large increases in the number of persons using PrEP in the USA. However, recent data on pre-exposure prophylaxis (PrEP) use at the state level indicate that people living in the Southern United States are underserved by PrEP relative to their epidemic need. We sought to review possible reasons for inequitable uptake of PrEP in the South and identify implementation approaches to increase PrEP uptake in the South.
Recent Findings
Published literature, data on the locations of PrEP service providers, recent data on PrEP utilization from pharmacy prescription databases, HIV surveillance data and government data on healthcare providers, and health literacy indicate a confluence of factors in the South that are likely limiting PrEP uptake. A variety of approaches are needed to address the complex challenges to PrEP implementation in the South. These include considering alternative PrEP provision strategies (e.g., pharmacy-based PrEP, telemedicine-delivered PrEP), conducting gain-based stigma-reduction campaigns, increasing capacity for reimbursement for PrEP medications and services through policy change to expand Medicaid and to preserve access to Affordable Care Act–compliant health plans, expanding STI screening programs and improving integration of PrEP offering with delivery of positive STI results, using mHealth tools to screen groups at highest risk for HIV (e.g., men who have sex with men) periodically to increase correct perception of risk, and streamlining clinical procedures to allow same-day PrEP starts for patients without obvious medical contraindications.
Summary
Overcoming the structural, capacity, and policy challenges to increasing PrEP uptake in the South will require innovations in clinical approaches, leveraging technologies, and policy changes. The South has unique challenges to achieving equitable PrEP uptake, and addressing key barriers to expanded PrEP use will require multisectoral responses.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>31177363</pmid><doi>10.1007/s11904-019-00447-4</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1548-3568 |
ispartof | Current HIV/AIDS reports, 2019-08, Vol.16 (4), p.259-269 |
issn | 1548-3568 1548-3576 1548-3576 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7117066 |
source | MEDLINE; SpringerLink Journals |
subjects | Anti-HIV Agents - therapeutic use Emtricitabine - therapeutic use Epidemics HIV HIV Infections - drug therapy HIV Infections - prevention & control Homosexuality, Male Human immunodeficiency virus Humans Implementation Science (E Geng Male Mass Screening Medication Adherence - psychology Medicine Medicine & Public Health Patient Protection and Affordable Care Act Pharmacy Pre-Exposure Prophylaxis - methods Prophylaxis Safe Sex - psychology Section Editor Sexual and Gender Minorities Social Stigma Telemedicine Tenofovir - therapeutic use Topical Collection on Implementation Science United States |
title | Implementation Strategies to Increase PrEP Uptake in the South |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T13%3A54%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Implementation%20Strategies%20to%20Increase%20PrEP%20Uptake%20in%20the%20South&rft.jtitle=Current%20HIV/AIDS%20reports&rft.au=Sullivan,%20Patrick%20S.&rft.date=2019-08-01&rft.volume=16&rft.issue=4&rft.spage=259&rft.epage=269&rft.pages=259-269&rft.issn=1548-3568&rft.eissn=1548-3576&rft_id=info:doi/10.1007/s11904-019-00447-4&rft_dat=%3Cproquest_pubme%3E2255457893%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2258208467&rft_id=info:pmid/31177363&rfr_iscdi=true |